ENTPD1 and allergic rhinitis: Serum CD39 levels in allergic rhinitis are reduced, particularly in moderate-to-severe cases, indicating that serum CD39 may serve as a promising diagnostic biomarker with significant potential for stratifying disease severity in allergic rhinitis [199].